BioSpace News Archive

Proteor USA, LLC, a wholly owned subsidiary of the France based, Proteor Group, has signed an agreement with Ottobock to acquire a significant portion of the lower limb prosthetics portfolio of Freedom Innovations which demonstrates Proteor’s continued commitment and investment in the worldwide prosthetic industry.

Pfizer Canada and B ioNTech will continue regular and open dialogue with Health Canada providing results from their ongoing Phase 3 study

Neoantigens, tiny markers that arise from cancer mutations, flag cells as cancerous and could be the key to unlocking a new generation of immunotherapies.

On October 8 and 9, the National Organization for Rare Disorders (NORD®) virtually hosted the 2020 Rare Diseases and Orphan Products Breakthrough Summit, the first time the organization representing over 25 million Americans impacted by rare diseases has presented the conference exclusively online

A new era of healthcare was ushered in today as Atrium Health and Wake Forest Baptist Health, including Wake Forest School of Medicine, officially joined together as a single enterprise, Atrium Health.

Amwell®, (NYSE: AMWL) (the “Company”) a national telehealth leader, today announced the appointment of Ms. Deborah C. Jackson to the Company’s Board of Directors, effective immediately.

Leaders in many top organizations and institutions have played a major role in using computational intelligence and pushing the boundaries of how the Wolfram technology stack is leveraged for innovation across fields and disciplines.

- New data from the Phase 2 OASIS trial and its open-label extension for etrasimod in ulcerative colitis - Arena sponsored symposium: Opening the Door to Emerging Investigational Treatments in Ulcerative Colitis: What Awaits Us? [09-October-2020] SAN DIEGO , Oct. 9, 2020 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) will present new data from

Celerion , a leading clinical research organization (CRO) provider to the biopharmaceutical industry, will deliver a key address on the final day of the V

Vystar® Corporation paid off more than $2 million in debt since July 1, 2020, including paying off multiple notes and lines of credit in September 2020, and consolidating other debt as it enters the peak retail holiday shopping season and the fourth quarter with its RxAir® UV-C Light air purifier line and Rotmans’ home furnishings poised to fill urgent needs amid the COVID-19 pandemic.